Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatremia - a randomized, double-blind, placebo-controlled study

Publication at Faculty of Physical Education and Sport, Faculty of Medicine in Hradec Králové |

2010

Abstract

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diurecits on ascites in patients with cirrhosis without hyponatremia - a randomized, double-blind, placebo-controlled study which was performed in many European hospitals.

Keywords

cirrhosis without hyponatremia satavaptan diuretics double-blind study placebo-controlled study

Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatremia - a randomized, double-blind, placebo-controlled study

Abstract

Keywords

People